ENDOGLIN (CD105): A marker of tumour vasculature for assessment of malignant potential of oral submucous fibrosis
The present study was first immunohistochemical study to demonstrate MVD, MVP and MVAP with CD105 expression in OSMF cases. However, well-designed studies with larger sample size is required to validate CD105 as a reliable biomarker for malignant transformation in future research.
Authors
- Subraj Shetty (ORCID: https://orcid.org/0000-0002-0849-1655)
- Sourab Kumar
- Sandeep Kale
- Treville Pereira (ORCID: https://orcid.org/0000-0001-5662-5235)
- Pooja Kamat (ORCID: https://orcid.org/0000-0002-7597-0197)
- Sandhya Tamgadge
Institutions
- D.Y. Patil University (IN)
Publication Details
- Journal
- Journal of Oral and Maxillofacial Pathology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.4103/jomfp.jomfp_67_24
- Primary Topic
- Oral Health Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00